Compugen (CGEN) Cost of Revenue (2009 - 2026)
Compugen's (CGEN) quarterly Cost of Revenue came in at $1.8 million in Q1 2026, down 24.0% year-on-year from $2.4 million in Q1 2025, and down 48.42% quarter-over-quarter from $3.5 million in Q4 2025.
Compugen (CGEN) Cost of Revenue (2009 - 2026) Analysis & Trends
Compugen has disclosed Cost of Revenue across 15 years of filings, most recently posting $1.8 million for Q1 2026.
- Cost of Revenue for Q1 2026 came in at $1.8 million, down 24.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.7 million (up 5.43% YoY), and the FY2025 annual result was $9.3 million, up 16.66% from the prior year.
- Cost of Revenue came in at $1.8 million for Q1 2026 at Compugen, down from $3.5 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $3.6 million in Q3 2024 to a low of $675000.0 in Q4 2024.
- The 5-year median for Cost of Revenue is $1.8 million (2026), against an average of $2.0 million.
- Across the five-year window, Cost of Revenue slumped 66.32% in 2024 and soared 423.85% in 2025, its largest moves.
- Compugen's Cost of Revenue stood at $975000.0 in 2022, then surged by 105.54% to $2.0 million in 2023, then plunged by 66.32% to $675000.0 in 2024, then jumped by 423.85% to $3.5 million in 2025, then plunged by 48.42% to $1.8 million in 2026.
- The last three Cost of Revenue figures came in at $1.8 million (Q1 2026), $3.5 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 64.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 48,670.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 392.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 2.05 Mn |
| 10 | Compugen | 191.95 Mn | 100.20 Mn | 352,000.00 | 1.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.82 Mn |
| Mar 31, 2026 | 1.82 Mn |
| Dec 31, 2025 | 3.54 Mn |
| Dec 31, 2025 | 3.54 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 2.40 Mn |
| Mar 31, 2025 | 2.40 Mn |
| Dec 31, 2024 | 675,000.00 |
| Dec 31, 2024 | 675,000.00 |
| Sep 30, 2024 | 3.60 Mn |
| Sep 30, 2024 | 3.60 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Dec 31, 2023 | 2.00 Mn |